SciELO - Scientific Electronic Library Online

vol.80 issue4Are soft neurological signs relevant in schizophrenia?: A review of current evidenceMyasthenia gravis author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand




  • Have no cited articlesCited by SciELO

Related links

  • Have no similar articlesSimilars in SciELO


Revista de Neuro-Psiquiatría

Print version ISSN 0034-8597


CASAVILCA-ZAMBRANO, Sandro A et al. Cognitive impairment due to adjuvant chemotherapy in breast cancer patients: A problem awaiting definition in Peru. Rev Neuropsiquiatr [online]. 2017, vol.80, n.4, pp.239-246. ISSN 0034-8597.

Chemotherapy-induced cognitive impairment is a poorly understood biological process; however, there is evidence that it could affect patients in adjuvant treatment for breast cancer whose incidence varies widely according to the study population, the therapeutic scheme applied and the methodology used in its evaluation. The present review seeks to initiate discussions about the need to generate information in our milieu about this disorder, in order to propose preventive and control strategies by healthcare personnel staff, and improve the quality of life of patients undergoing this type of treatment.

Keywords : Cognitive impairment; adjuvant chemotherapy; breast cancer.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )


Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License